JOURNALISTS CAN NOW REPORT ON FAMILY LAW CASES IN COURT – IS THIS GOOD OR BAD?
In a milestone development, accredited journalists can report in family law courts on cases which decide the future and wellbeing of children whose parents are divorcing. They can also report on cases which determine if children should be taken into care.
Essential best practices to mitigate greenwashing
In the first article of the series, which explored ‘What greenwashing risks mean for the legal profession’, we outlined the key principles that legal and risk management professionals are to follow to mitigate such risks. These include:
What greenwashing risks mean for the legal profession
As sustainability issues take center stage in corporate governance, could your company be at risk of inadvertently misleading investors or consumers?
New Legal Exemptions for SMES: key updates from the Thai personal data protection committee
On 8 January 2025, the Thai Government Gazette published a royal decree introducing a Notification on Exemption from Keeping a Record of Processing Activities for Data Controllers who are Small or Medium-Sized Enterprises B.E.
Navigating the 7th edition of th Siac Rules, 2025: Highlighting 10 key features
The Singapore International Arbitration Centre (SIAC) has unveiled the 7th edition of its Arbitration Rules, effective 1 January 2025.
Can Singapore learn from the European Health Data Space Act (“EHDSA”)? A discussion on the NEHR and the Proposed Health Information Bill (“SG HIB”)
Introduction The National Electronic Health Record (“NEHR”) system was set up with the goal of serving as a repository to collect different types of data of the patients’ summary health conditions and records based on their encounters with healthcare professions and clinicians throughout their life.
Mergers and Acquisitions – David Getting Ready for the Takeover
Following our first article “Goliath taking over David”[1], we will now look at ways in which David should get itself ready for such a transaction.
Mergers and Acquisitions – As Goliath takes over David – are the risks worth it?
Today’s mergers and acquisitions landscape involves more transactions between companies of difference in sizes (in terms of assets,
Taking the driving seat on pharma and life science investments
Investments in the life science and pharmaceutical industries are a different ballgame.
A Practical Checklist of Things to Avoid with New Launches of Prescription-Only Medicines in Singapore
Pharmaceutical companies that plan launches of prescription-only medicines need to be aware: there are regulatory matters in Singapore things which can interrupt your launch if they’re not sufficiently attended to.